Results 91 to 100 of about 72,405 (280)

Measuring infliximab and adalimumab drug and antibodies in Crohn's disease and ulcerative colitis

open access: yes, 2020
The anti-TNF therapies infliximab and adalimumab have revolutionized the treatment of inflammatory bowel disease, being very effective in many patients.

core  

Treatment of pediatric autoimmune liver disease beyond prednisolone and azathioprine in a cohort of 115 patients

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Pediatric autoimmune hepatitis (pAIH) is an acute or chronic inflammatory liver disease, caused by a dysregulation of the immune system. Autoimmune sclerosing cholangitis (ASC) additionally affects the bile ducts. Traditional first‐line treatment (FLT) consists of prednisolone and azathioprine.
Marie Korell   +10 more
wiley   +1 more source

Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study

open access: yesGut and Liver, 2015
Background/AimsIn patients with corticosteroid-refractory ulcerative colitis (UC), cyclosporine or infliximab may be added to the treatment regimen to induce remission.
doaj   +1 more source

A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab early colectomy

open access: yesTherapeutic Advances in Chronic Disease, 2019
Background: Early intervention for acute severe ulcerative colitis (ASUC) improves outcomes. Outcomes and healthcare costs for an infliximab-first and colectomy-first approach were compared.
Abhinav Vasudevan   +4 more
doaj   +1 more source

Infliximab-Induced Optic Perineuritis and Facial Myositis

open access: yes, 2022
Optic neuritis is an inflammatory condition involving the optic nerve with autoimmune, demyelinating, toxic or infectious etiologies. Myositis is a rare but reported complication of infliximab (1), whereas the incidence of infliximab-induced optic ...
Loulwah Mukharesh; Amanda Tinsley
core  

Effectiveness and Safety of Infliximab in Two Cases of Severe Chondrocalcinosis: Nine Years of Follow-Up [PDF]

open access: yes, 2014
Objectives. To investigate the efficacy of infliximab in the treatment of severe calcium pyrophosphate deposition diseases (CPPD). Methods. Two patients with severe CPPD and diffuse idiopathic skeletal hyperostosis- (DISH-) like phenotype are described ...
Bruno F. Bettencourt   +13 more
core   +2 more sources

High rates of flares after anti‐tumor necrosis factor withdrawal in pediatric inflammatory bowel disease: A multi‐center study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Outcomes of anti‐tumor necrosis factor (anti‐TNF) discontinuation in pediatric patients with inflammatory bowel disease (IBD) remain unclear. We aimed to quantify relapse and biologic re‐initiation rates following anti‐TNF withdrawal in patients in sustained clinical remission for at least 6 months. Methods Patients' characteristics
Maya Granot   +24 more
wiley   +1 more source

Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience

open access: yesReumatismo, 2011
Objective: We report the incidence and treatment of infusion reactions to infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor a, in a large cohort of patients with rheumatoid arthritis.
S. Todesco, P. Ostuni, C. Botsios
doaj   +1 more source

Profile of infliximab in the treatment of pediatric Crohn’s disease

open access: yes, 2015
Jaroslaw Kierkus,1 Edyta Szymanska,2 Grzegorz Oracz,1 Anna Wiernicka,1 Maciej Dadalski1 1Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, 2Department of Pediatrics, Nutrition and Metabolic Disorders, The Children’s ...
Szymanska E   +4 more
core  

Obesity in paediatric inflammatory bowel disease: The emerging double burden—A narrative review

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Obesity is increasingly recognised in paediatric inflammatory bowel disease (IBD), challenging the traditional view of paediatric IBD as a condition primarily associated with undernutrition, impaired growth, and delayed puberty. In parallel with the global rise in childhood obesity, overweight and obesity are now increasingly reported in ...
Martina Di Benedetto   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy